Skip to main content
. 2022 Jul 28;13:913424. doi: 10.3389/fimmu.2022.913424

Table 3.

Pre-seasonal omalizumab is more effective than traditional pharmacotherapy.

Pre-seasonal omalizumab Traditional pharmacotherapy P-value
Baseline CSMS 4.00[2.83,4.96] 2.88[2.25,4.25] 0.000
CSMS after treatment 0.67[0.00,1.83] 1.42[0.71,2.29] 0.017
CSMS improvement1 2.75 ± 1.42 1.22 ± 0.99 0.000

1CSMS improvement: CSMS after treatment – baseline CSMS.